Noninvasive brain stimulation for migraine: A bibliometric analysis of scientific research with thematic and keyword mapping.

Noninvasive brain stimulation (NIBS) is gaining attention as a migraine treatment. This research analyzed 411 studies from 1992 to 2024. The analysis looked at publication trends, collaboration patterns, and thematic developments. Annual publications increased by 11.75% since 2013, especially after FDA approval of transcranial magnetic stimulation. The United States contributed the most research, making up 33.1% of the total. Denmark had the highest citation impact, averaging 93.1 citations per publication. The study identified six main research themes and key areas needing more exploration. It highlights the growing importance of NIBS in migraine therapy and the need for more collaborative efforts. This research could help guide future studies and improve treatment options. Understanding these trends may lead to better patient outcomes and more effective ways to manage migraines. Clinical relevance: This analysis highlights the increasing interest in noninvasive brain stimulation for migraine treatment, suggesting potential advancements in effective management strategies for patients.